Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grape Seed Extract for Circulation in Healthy Adults
NCT06440252Phase 3Completed
- Sponsor
- RDC Clinical
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in prehypertension, sponsored by RDC Clinical. Primary endpoint: Diastolic blood pressure at 11 weeks. Started Oct 2024; status: completed.
02
Conditions
prehypertension
Beyond the preview
Go deeper on NCT06440252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06440252.